Efficacy and Safety Study of MT10109L in the Treatment of Glabella Line(Including a Preliminary Study to Evaluate Safety of MT10109L)

NCT03894748 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Glabella Line Severity

Interventions

DRUG: Botulinum Toxin Type A

Sponsor

Medy-Tox